Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127360071 | 12736007 | 1 | I | 20160818 | 20160903 | 20160912 | 20160912 | EXP | NL-AMGEN-NLDSL2016119917 | AMGEN | 62.00 | YR | A | F | Y | 0.00000 | 20160912 | OT | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127360071 | 12736007 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 0.6 ML, Q3WK | U | 125031 | .6 | ML | SOLUTION FOR INJECTION | Q3W |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127360071 | 12736007 | 1 | Neutropenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127360071 | 12736007 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127360071 | 12736007 | Decreased appetite | |
| 127360071 | 12736007 | Diarrhoea | |
| 127360071 | 12736007 | Fluid intake reduced | |
| 127360071 | 12736007 | Insomnia | |
| 127360071 | 12736007 | Nausea | |
| 127360071 | 12736007 | Oral pain | |
| 127360071 | 12736007 | Pyrexia | |
| 127360071 | 12736007 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |